metyrapone has been researched along with EHS Tumor in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Seifter, E | 2 |
Critselis, AN | 1 |
Levenson, SM | 2 |
Rettura, G | 2 |
Seifter, J | 1 |
Zisblatt, M | 1 |
Levine, N | 1 |
2 other studies available for metyrapone and EHS Tumor
Article | Year |
---|---|
Effect of metyrapone and aminoglutethimide on the murine sarcoma (MuSV-M) and breast adenocarcinoma (C3HBA).
Topics: Adenocarcinoma; Aminoglutethimide; Animals; Female; Male; Mammary Neoplasms, Experimental; Metyrapon | 1979 |
Metyrapone-inhibited oncogenesis in mice inoculated with a murine sarcoma virus.
Topics: Animals; Diet; Metyrapone; Mice; Mice, Inbred Strains; Moloney murine leukemia virus; Organ Size; Sa | 1973 |